Cosmo Pharmaceuticals S.p.A. to Launch Phase III Trails on Diarrhoea Drug Rifamycin

ZURICH (Thomson Financial) - Cosmo Pharmaceuticals SpA said it is preparing phase III trails for its treatment for infectious diarrhoea, Rifamycin SV MMX, after previous trails proved successful.

MORE ON THIS TOPIC